74 related articles for article (PubMed ID: 38554489)
1. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction.
Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H
J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192
[TBL] [Abstract][Full Text] [Related]
2. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression.
Li L; You W; Wang X; Zou Y; Yao H; Lan H; Lin X; Zhang Q; Chen B
Phytomedicine; 2023 Jan; 108():154508. PubMed ID: 36332384
[TBL] [Abstract][Full Text] [Related]
3. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
[TBL] [Abstract][Full Text] [Related]
4. Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticles.
Hsu CY; Mustafa MA; Kumar A; Pramanik A; Sharma R; Mohammed F; Jawad IA; Mohammed IJ; Alshahrani MY; Ali Khalil NAM; Shnishil AT; Abosaoda MK
Pathol Res Pract; 2024 Apr; 256():155266. PubMed ID: 38554489
[TBL] [Abstract][Full Text] [Related]
5. Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles.
Qin L; Wu J
Environ Res; 2023 Dec; 239(Pt 1):116751. PubMed ID: 37507044
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products.
Lafta HA; AbdulHussein AH; Al-Shalah SAJ; Alnassar YS; Mohammed NM; Akram SM; Qasim MT; Najafi M
Curr Top Med Chem; 2023; 23(12):1104-1122. PubMed ID: 36722486
[TBL] [Abstract][Full Text] [Related]
7. The exploitation of enzyme-based cancer immunotherapy.
Chandan G; Saini AK; Kumari R; Chakrabarti S; Mittal A; Sharma AK; Saini RV
Hum Cell; 2023 Jan; 36(1):98-120. PubMed ID: 36334180
[TBL] [Abstract][Full Text] [Related]
8. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
Gaggero S; Witt K; Carlsten M; Mitra S
Front Immunol; 2020; 11():621225. PubMed ID: 33584718
[TBL] [Abstract][Full Text] [Related]
9. Targeting of the tumor immune microenvironment by metformin.
Wu Z; Zhang C; Najafi M
J Cell Commun Signal; 2022 Sep; 16(3):333-348. PubMed ID: 34611852
[TBL] [Abstract][Full Text] [Related]
10. Modulating the tumor immune microenvironment with nanoparticles: A sword for improving the efficiency of ovarian cancer immunotherapy.
Xu T; Liu Z; Huang L; Jing J; Liu X
Front Immunol; 2022; 13():1057850. PubMed ID: 36532066
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]